2 news items
Aspira Women's Health Reports First Quarter 2024 Financial Results
AWH
15 May 24
agreement with Anthem Blue Cross in California for reimbursement coverage of the Company's OvaSuite portfolio of risk assessment tests effective June 1
Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results
AWH
28 Mar 24
to the fee paid historically for Ova1. Aspira will be reimbursed at a rate of $897 for all OvaWatch and Ova1 tests processed for Medicare patients meeting
- Prev
- 1
- Next